MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.
Zeng Y, Yin L, Zhou J, Zeng R, Xiao Y, Black AR, Hu T, Singh PK, Yin F, Batra SK, Yu F, Chen Y, Dong J.
Zeng Y, et al. Among authors: zhou j.
Oncogene. 2022 Jul;41(31):3859-3875. doi: 10.1038/s41388-022-02399-3. Epub 2022 Jul 2.
Oncogene. 2022.
PMID: 35780183
Free PMC article.